Fundraising Fox

Omri Amirav Drory

Investor

General Partner at NFX · Board director at TwoStep Therapeutics · Board director at ImmuneBridge · Board director at Talus Bio

San Francisco Bay Area

Writes $500K – $5M checks · typically $3M

About

Omri Amirav-Drory is a founder-operator with TechBio lifecycle experience—founding Genome Compiler (acquired by Twist Bioscience), serving as Twist VP of Corporate Development and Innovation and acting as CEO during incubation.

Contact· self-published, not guessed

Invests in

AI & Machine LearningBiotechCrypto & Web3FintechMarketplaces

Board director at TwoStep Therapeutics

Intro paths

In turn, Omri can intro founders to TwoStep Therapeutics's investors below.

Co-founders at TwoStep Therapeutics

CMCaitlyn Miller
Caitlyn MillerCEO & Co-Founder
JCJennifer Cochran
Jennifer CochranCo-Founder
CBCarolyn Bertozzi
Carolyn BertozziCo-Founder
RLRonald Levy
Ronald LevyCo-Founder

Board director at ImmuneBridge

Intro paths

In turn, Omri can intro founders to ImmuneBridge's investors below.

Co-founders at ImmuneBridge

PP
Peretz PartenskyExecutive Officer, Director

Board director at Talus BioYC S21

Intro paths

YC

Omri went through Y Combinator (Summer 2021) — any YC alum in your network can reach them through the YC community.

GP

Their group partner at YC was Jared Friedman, YC Group Partner — the partner who ran Talus Bio's batch and knows the company first-hand. YC profile ↗

In turn, Omri can intro founders to Talus Bio's investors below.

Co-founders at Talus Bio

LPLindsay Pino

Experience

  1. EarthTraq CorporationBoard Membercurrent2026 — present
  2. PortalBoard Membercurrent2026 — present
  3. Cyclana BioBoard Membercurrent2025 — present
  4. ImmuneBridgeBoard Membercurrent2025 — present
  5. Powerhouse BiologyBoard Membercurrent2025 — present
  6. Permanence BioBoard Membercurrent2025 — present
  7. Radar TherapeuticsBoard Membercurrent2024 — presentSan Francisco Bay Area
  8. TwoStep TherapeuticsBoard Membercurrent2024 — presentSan Francisco Bay Area
  9. ZipBioBoard Membercurrent2023 — present
  10. CentivaxBoard Membercurrent2022 — present
  11. Renewal BioFounder & chairman of the boardcurrent2022 — presentRehovot, Center District, Israel
  12. PumpkinseedBoard Membercurrent2022 — present
  13. Talus BioBoard Membercurrent2021 — present
  14. Mana.bioBoard Membercurrent2021 — present
  15. Nanocarry TherapeuticsBoard Membercurrent2021 — present
  16. NFXGeneral Partnercurrent2020 — present
  17. Eleven TherapeuticsBoard Membercurrent2020 — present
  18. EdiTy TherapeuticsBoard Membercurrent2020 — present
  19. ImmunaiAdvisorcurrent2020 — present
  20. Light Bio, Inc.Board Membercurrent2020 — present
  21. 8400 - The Health NetworkMembercurrent2020 — present
  22. tech.bioFounding Partnercurrent2018 — present
  23. Mammoth BiosciencesAdvisorcurrent2016 — presentSan Francisco Bay Area
  24. IndieBioMentorcurrent2015 — presentSan Francisco Bay Area
  25. PsygaBioBoard Member2021 — 2026
  26. La Jolla LabsBoard Member2021 — 2026San Diego Metropolitan Area
  27. PANGEA TherapeuticsBoard Member2021 — 2026
  28. Pepper BioBoard Member2021 — 2025
  29. Gilboa TherapeuticsBoard Member2021 — 2024
  30. resistanceBioBoard Member2022 — 2024
  31. C2i GenomicsBoard Observer2019 — 2024
  32. AGE1Mentor2019 — 2023
  33. Loop GenomicsAdvisor2015 — 2022San Francisco Bay Area
  34. Wild BiotechBoard Member2019 — 2022
  35. Armada BiosystemsBoard Member2019 — 2021
  36. Twist BioscienceHead of Corporate Development2016 — 2018San Francisco Bay Area
  37. Singularity UniversityIsraeli Community Ambassador2015 — 2016Tel-Aviv
  38. Genome Compiler Corp. Acquired by Twist BioscienceFounder & CEO2011 — 2016San Francisco Bay Area
  39. Stanford University school of medicinePostdoctoral associate2007 — 2011
  40. Singularity Universityattendee2011

Skills & more

Genomics79Lifesciences45Bioinformatics87Biochemistry41Molecular Biology77Biotechnology44Computational Biology29Genetics31Protein Chemistry29Protein Purification8Sequencing5Immunology6
+12 moreDNATechnology TransferPersonalized MedicineBiomedical EngineeringPCRCancerScientific WritingProtein ExpressionBiophysicsProteomicsDrug DiscoveryIn Vitro

From Omri's professional profile.

Deals · 5

TwoStep TherapeuticsBoard seat

via NFX · filed Jan 2026 · $62.2M raise

ImmuneBridgeBoard seat

via NFX · filed Apr 2025 · $7.1M raise

Talus BioBoard seat

via NFX · filed Aug 2024 · $11.3M raise

ResistanceBioBoard seat

via NFX · filed Jan 2024 · $12.8M raise

La Jolla LabsBoard seat

via NFX · filed Oct 2021 · $3.5M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at NFX

Network4

Investors connected to Omri in public investor directories — a warm-intro map.

Frequently asked questions

Who is Omri Amirav Drory?
Omri Amirav-Drory is a founder-operator with TechBio lifecycle experience—founding Genome Compiler (acquired by Twist Bioscience), serving as Twist VP of Corporate Development and Innovation and acting as CEO during incubation.
Where does Omri Amirav Drory work?
Omri Amirav Drory is General Partner at NFX and Board director at TwoStep Therapeutics and Board director at ImmuneBridge and Board director at Talus Bio.
What does Omri Amirav Drory invest in?
Omri Amirav Drory invests in AI & Machine Learning, Biotech, Crypto & Web3, Fintech, Marketplaces.
What check size does Omri Amirav Drory write?
Omri Amirav Drory typically writes checks of $500K – $5M.
What boards does Omri Amirav Drory sit on?
Omri Amirav Drory holds tracked board seats at ImmuneBridge, La Jolla Labs, ResistanceBio, Talus Bio, TwoStep Therapeutics.
Where did Omri Amirav Drory go to school?
Omri Amirav Drory studied at Stanford University (Postdoctoral, Biochemistry and Molecular Biology); Tel Aviv University (Doctor of Philosophy (Ph.D.), Biochemistry); Tel Aviv University (Bachelor of Science - BS, Biochemistry and Molecular Biology).

Founder mafias

Same school

Shared employers